briviact

Generic: brivaracetam

Labeler: ucb, inc.
NDC Directory HUMAN PRESCRIPTION DRUG NDA Inactive Finished

Drug Facts

Product Profile

Brand Name briviact
Generic Name brivaracetam
Labeler ucb, inc.
Dosage Form INJECTION, SUSPENSION
Routes
INTRAVENOUS
Active Ingredients

brivaracetam 50 mg/5mL

Manufacturer
UCB, Inc.

Identifiers & Regulatory

Product NDC 50474-970
Product ID 50474-970_3e7903ad-236d-1a65-e063-6294a90a6f44
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category NDA
Application Number NDA205837
DEA Schedule cv
Listing Expiration 2026-12-31
Marketing Start 2016-05-12

Pharmacologic Class

Mechanism of Action
epoxide hydrolase inhibitors [moa]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 50474970
Hyphenated Format 50474-970

Supplemental Identifiers

RxCUI
1739749 1739754 1739761 1739766 1739768 1739770 1739772 1739774 1739776 1739778 1739780 1739782 1739785 1739788
UNII
U863JGG2IA
NUI
N0000192345

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name briviact (source: ndc)
Generic Name brivaracetam (source: ndc)
Application Number NDA205837 (source: ndc)
Routes
INTRAVENOUS
source: ndc

Resolved Composition

Strengths
  • 50 mg/5mL
source: ndc
Packaging
  • 10 VIAL, GLASS in 1 CARTON (50474-970-75) / 5 mL in 1 VIAL, GLASS (50474-970-63)
source: ndc

Packages (1)

50474-970-75 10 VIAL, GLASS in 1 CARTON (50474-970-75) / 5 mL in 1 VIAL, GLASS (50474-970-63)

Ingredients (1)

brivaracetam (50 mg/5mL)

Linked Drug Pages (1)

Briviact ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["INTRAVENOUS"], "spl_id": "3e7903ad-236d-1a65-e063-6294a90a6f44", "openfda": {"nui": ["N0000192345"], "unii": ["U863JGG2IA"], "rxcui": ["1739749", "1739754", "1739761", "1739766", "1739768", "1739770", "1739772", "1739774", "1739776", "1739778", "1739780", "1739782", "1739785", "1739788"], "spl_set_id": ["3cf2f439-0e97-443e-8e33-25ecef616f6c"], "pharm_class_moa": ["Epoxide Hydrolase Inhibitors [MoA]"], "manufacturer_name": ["UCB, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "10 VIAL, GLASS in 1 CARTON (50474-970-75)  / 5 mL in 1 VIAL, GLASS (50474-970-63)", "package_ndc": "50474-970-75", "marketing_start_date": "20160512"}], "brand_name": "Briviact", "product_id": "50474-970_3e7903ad-236d-1a65-e063-6294a90a6f44", "dosage_form": "INJECTION, SUSPENSION", "pharm_class": ["Epoxide Hydrolase Inhibitors [MoA]"], "product_ndc": "50474-970", "dea_schedule": "CV", "generic_name": "brivaracetam", "labeler_name": "UCB, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Briviact", "active_ingredients": [{"name": "BRIVARACETAM", "strength": "50 mg/5mL"}], "application_number": "NDA205837", "marketing_category": "NDA", "marketing_start_date": "20160512", "listing_expiration_date": "20261231"}